Key facts
- This page summarizes Sam Lee's Form 4 filing for Cocrystal Pharma, Inc. (COCP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Oct 2024, 16:05.
Sam Lee - 09 Oct 2024 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)
- Reporting relationship
- President and Co-CEO
- Issuer ticker
- COCP
- Reported as of
- 09 Oct 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Oct 2024, 16:05:57 UTC
- Prior SEC filing
- 20 Jul 2023
- Next SEC filing
- 13 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sam Lee
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sam Lee filed Form 4 for Cocrystal Pharma, Inc. (COCP) on 11 Oct 2024.
Change
- Previous filing in this sequence was filed on 20 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
COCP
transaction
Common Stock
Award
- Transaction value
- Shares
- +40,000
- Change %
- +110%
- Price
- Shares after
- 76,355
- Date
- 09 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan.